As of Apr 26
| +0.0035 / +28.00%|
The 1 analysts offering 12-month price forecasts for Inspyr Therapeutics Inc have a median target of 0.85, with a high estimate of 0.85 and a low estimate of 0.85. The median estimate represents a +5,212.50% increase from the last price of 0.02.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.